What does the clause after the comma, which states that sporadic frontotemporal dementia accounts for only 1–10 % of all frontotemporal dementia cases, mean regarding my risk? | Rounds What does the clause after the comma, which states that sporadic frontotemporal dementia accounts for only 1–10 % of all frontotemporal dementia cases, mean regarding my risk? | Rounds
Loading...

What does the clause after the comma, which states that sporadic frontotemporal dementia accounts for only 1–10 % of all frontotemporal dementia cases, mean regarding my risk?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Interpreting “sporadic frontotemporal dementia accounts for 1–10%”

The clause describes the fraction of all frontotemporal dementia (FTD) cases in a population that are classified as “sporadic,” not the chance that a specific individual will develop FTD. A population proportion does not directly translate into an individual risk estimate.

Meaning of “sporadic” for risk assessment

“Sporedic” in FTD literature generally indicates that no clear inherited genetic cause or strong family history is identified in the person diagnosed. The key implication is that “sporadic” is a case-label used for how FTD is distributed across diagnoses at the group level.

Why 1–10% does not define personal risk

The 1–10% figure is an incidence mix across all FTD cases, not a probability of developing FTD for an individual. Personal risk depends on factors such as age, the presence of symptoms, family history, and whether a pathogenic genetic variant is present. Even when a category represents 1–10% of cases, the absolute risk for any given person can still be very low or may be higher depending on individual risk factors.

How to translate this into a practical risk question

A more relevant risk question is whether the person has major risk modifiers, such as:

  • First-degree relatives with FTD or related neurodegenerative diseases.
  • Known pathogenic variants in genes associated with FTD.
  • Onset of compatible symptoms that could warrant neurologic evaluation.

Information needed to estimate risk for an individual

A direct risk estimate usually requires details that determine whether the person’s situation matches “sporadic” versus “familial/genetic” pathways. The following information is typically needed:

  • Any FTD or motor neuron disease in first-degree and second-degree relatives.
  • Ages at diagnosis in relatives.
  • Whether any genetic testing has been performed in the family.

Suggested next step for individualized counseling

Clarification of the exact sentence and definition used in the source (how the source defines “sporadic”) is needed to interpret the statistic correctly. If risk estimation is desired, neurologic genetics or a neurologist can review family history and determine whether genetic counseling or testing is appropriate.

Clarification request

The exact wording of the full sentence (including the clause before the comma) is needed to determine what the source is comparing (for example, whether “sporadic” is being contrasted with specific genetic subtypes). Sharing the sentence verbatim allows the 1–10% statistic to be interpreted in the correct context for meaning and implications for risk.

Related Questions